Allogene Therapeutics, Inc.ALLONASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank50
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-209.31M
Near historical average
Percentile
P50
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-219.90M
Historical baseline
PeriodValueYoY Change
TTM$-209.31M+23.4%
2024$-273.20M+16.6%
2023$-327.74M+2.3%
2022$-335.54M-86.2%
2021$-180.19M+30.2%
2020$-258.24M-27.8%
2019$-202.01M-4.8%
2018$-192.84M-9642000.0%
2017$-2000.00-